Benralizumab: Targeting the IL-5 Receptor in Severe Eosinophilic AsthmaAbstract. For patients with difficult-to-control, severe bronchial asthma, highly effective, targeted ...
Benralizumab: Targeting the IL-5 Receptor in Severe Eosinophilic AsthmaAbstract. Abstract:For patients with difficult-to-control, severe bronchial asthma, highly ...